While most individuals recover without complications, Parvovirus B19 can lead to severe outcomes in certain populations. Pregnant women may experience fetal loss or hydrops fetalis. Individuals with hemolytic disorders, such as sickle cell disease, may suffer from aplastic crisis. Immunocompromised patients are at risk for chronic anemia. Early identification and management of these complications are essential for improving patient outcomes.
